What clinicians say about clinical trials, and why.
Source-linked reports for Medical Affairs, built for your AI agent first. Your agent can find a report, buy it and read the evidence behind every finding. You can read the same report yourself, and weekly updates track what changes.
Explore the report previews
| Trial | Indication | Phase | Claims | HCP sources | Size | Updated | Preview |
|---|---|---|---|---|---|---|---|
| QUINTESSENTIAL-2 NCT06615479 · Juno Therapeutics, Inc., a Bristol-Myers Squibb Company | Multiple myeloma | Phase 3 | 227 | 8 | Focused | 2026-10-09 | Preview |
| CheckMate 744 NCT02927769 · Bristol-Myers Squibb | Hodgkin lymphoma | Phase 2 | 197 | 19 | Standard | 2026-10-09 | Preview |
| PROUD-PV NCT01949805 · AOP Orphan Pharmaceuticals AG | Polycythemia vera | Phase 3 | 749 | 30 | Standard | 2026-10-08 | Preview |
| NEONIPIGA NCT04006262 · GERCOR - Multidisciplinary Oncology Cooperative Group | Gastroesophageal adenocarcinoma | Phase 2 | 1,222 | 60 | Deep | 2026-10-08 | Preview |
| CALGB-10403 NCT00558519 · Alliance for Clinical Trials in Oncology | Leukemia | Phase 2 | 1,065 | 28 | Standard | 2026-10-08 | Preview |
| MARS2 NCT02040272 · Royal Brompton & Harefield NHS Foundation Trust | Mesothelioma | Not applicable | 1,094 | 131 | Deep | 2026-10-08 | Preview |
| EURTAC NCT00446225 · Spanish Lung Cancer Group | Non-small cell lung cancer | Phase 3 | 210 | 9 | Focused | 2026-10-08 | Preview |
| SURTIME NCT01099423 · European Organisation for Research and Treatment of Cancer - EORTC | Renal cell carcinoma | Phase 3 | 427 | 32 | Standard | 2026-10-08 | Preview |
| MSLT-II NCT00297895 · Saint John's Cancer Institute | Melanoma | Not applicable | 499 | 36 | Standard | 2026-10-08 | Preview |
| EA3191 NCT04671667 · National Cancer Institute (NCI) | Head and neck squamous cell carcinoma | Phase 2 | 116 | 9 | Focused | 2026-10-07 | Preview |
10 of 10 reports
# What Erudio is and how to query it
curl https://www.erudio.com/llms.txt
# Every report, with counts, version and links
curl https://www.erudio.com/catalog.json
# One report as JSON or Markdown
curl https://www.erudio.com/reports/{slug}.json{
"mcpServers": {
"erudio": { "url": "https://mcp.erudio.com/mcp" }
}
}
# then ask your agent:
# search_reports({ "drug": "carboplatin" })- 10 reports
- weekly updates
- versioned editions
- every claim source-linked
Every report works with your agent. Enterprise adds the whole corpus.
One trial, one report, agent included
What clinicians said about a trial in podcasts, videos and posts, why their readings differ, and the source behind every view. Every report comes with JSON, Markdown and MCP read access for your agent, with no enterprise contract. Buy the current edition, or follow a trial with 3, 6 or 12 months of weekly updates.
The whole corpus, for your agents
Search across all the HCP podcasts, videos and posts we index, look up clinicians, and read every report your organization licenses, from ChatGPT, Claude, Grok or your own agent. Ask “prep me for my meetings with these five oncologists” and get sourced answers.
Each report leads to the open question for Medical Affairs.
What evidence would make molecular response actionable after blood counts normalize?
Read the PROUD-PV preview →- commentary sources cited
- 30
- commentary sources cited
- verified claims
- 749
- verified claims
- voices cited
- 33
- voices cited
- findings
- 11
- findings
How a report is built
Every report separates what clinicians said from what the primary evidence establishes. We never turn commentary into an efficacy verdict or a consensus.
- 01
Resolve the trial
One registry record, its aliases, no look-alikes
- 02
Gather sources
Podcasts, videos and X posts that name the trial
- 03
Screen and extract
Each view, question and reason becomes a claim
- 04
Audit
Every claim checked against its original passage
- 05
Compose
What clinicians said and why, beside the primary facts
- 06
Review
Findings checked for fidelity and overclaiming
- 07
Version and publish
A hashed, versioned edition with a changelog
- Read the methods →
Built around the jobs Medical Affairs already does.
Meeting prep
Readout reaction
Congress briefing
Advisory boards
Competitive context
Evidence gaps
Launch and access signals
Trial watchlist
Education needs assessment
Public sources only. Every claim linked. Every edition versioned, with corrections in the open.
- Security-only SOC 2 Type II report, available under NDA
- Founders published on HCP conversation in BMJ, JAMA Oncology and the European Heart Journal
- Reports state what they do not cover, on every page
- Non-promotional: no efficacy verdicts, consensus scores or rankings. About Erudio